论文部分内容阅读
目的探讨准分子激光上皮下角膜磨镶术(LASEK)治疗超高度近视(≥-10.00D)的远期效果。方法收集2003年12月~2006年1月在我院行LASEK的超高度近视患者83例151只眼,观察25~49个月,平均(35.34±6.45)月;术前裸眼视力0.01~0.1,平均0.053±0.025,最佳矫正视力0.5~1.2;平均0.998±0.145,术前屈光度-10.00~-14.50D,平均(-11.01±1.19)D。结果术后25~49个月回访,裸眼视力0.2~1.5,平均1.01±0.26,≥1.0者120眼占79.47%,≥0.6者142眼占94.04%,haze 6眼,0.5级5眼,1级1眼。结论LASEK治疗超高度近视的远期疗效安全可靠,疗效稳定,并发症少,是治疗超高度近视较好的术式之一。
Objective To investigate the long-term effect of laser subepithelial keratomileusis (LASEK) on ultra-high myopia (≥-10.00D). Methods A total of 151 eyes of 83 patients with ultra-high myopia who underwent LASEK in our hospital from December 2003 to January 2006 were collected. The average visual acuity was 0.01 ~ 0.1 (35.34 ± 6.45 months) Average 0.053 ± 0.025, best corrected visual acuity 0.5 ~ 1.2; average 0.998 ± 0.145, preoperative refraction -10.00 ~ -14.50D, mean (-11.01 ± 1.19) D. Results The patients were followed up 25-49 months after operation. The uncorrected visual acuity was 0.2-1.5 with an average of 1.01 ± 0.26, with 120 eyes of ≥1.0 accounting for 79.47%, 142 eyes of ≥0.6 accounting for 94.04%, haze of 6 eyes, 0.5 eyes of 0.5 eyes, 1 eye. Conclusion The long-term efficacy of LASEK in the treatment of super-high myopia is safe, reliable and stable with few complications. It is one of the best surgical procedures for the treatment of super-myopia.